Arcus Biosciences (RCUS) Other Working Capital Changes (2017 - 2025)
Historic Other Working Capital Changes for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$26.0 million.
- Arcus Biosciences' Other Working Capital Changes fell 13880.6% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.0 million, marking a year-over-year decrease of 72580.65%. This contributed to the annual value of -$56.0 million for FY2024, which is 1764.71% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Other Working Capital Changes is -$26.0 million, which was down 13880.6% from -$160.0 million recorded in Q2 2025.
- Arcus Biosciences' Other Working Capital Changes' 5-year high stood at $67.0 million during Q3 2024, with a 5-year trough of -$339.6 million in Q4 2021.
- For the 5-year period, Arcus Biosciences' Other Working Capital Changes averaged around -$43.1 million, with its median value being -$27.0 million (2022).
- Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 30884272.73% in 2021, then soared by 30937.5% in 2024.
- Quarter analysis of 5 years shows Arcus Biosciences' Other Working Capital Changes stood at -$339.6 million in 2021, then soared by 89.99% to -$34.0 million in 2022, then skyrocketed by 50.0% to -$17.0 million in 2023, then plummeted by 147.06% to -$42.0 million in 2024, then skyrocketed by 38.1% to -$26.0 million in 2025.
- Its Other Working Capital Changes was -$26.0 million in Q3 2025, compared to -$160.0 million in Q2 2025 and -$28.0 million in Q1 2025.